Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 149 clinical trials for: 150 miles

Recruiting
A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema
  • Recruiting
NCT06807268
Sex: All
Age: 6 - 11
Locations: 31
View study
Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
  • Recruiting
NCT05253651
Sex: All
Age: 18+
Locations: 225
View study
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  • Recruiting
NCT07028853
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
  • Recruiting
NCT06616194
Sex: All
Age: 12 - 17
Locations: 50
View study
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  • Recruiting
NCT06989437
Sex: All
Age: 18+
Locations: 33
View study
Recruiting
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
  • Recruiting
NCT06551324
Sex: Male
Age: 18+
Locations: 50
View study
Recruiting
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
  • Recruiting
NCT07013474
Sex: All
Age: 18+
Locations: 75
View study
Recruiting
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
  • Recruiting
NCT06866405
Sex: All
Age: 0+
Locations: 50
View study
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
  • Recruiting
NCT05156398
Sex: All
Age: 6 - 17
Locations: 50
View study
...